Compare XERS & AFYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XERS | AFYA |
|---|---|---|
| Founded | 2005 | 1999 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2018 | 2019 |
| Metric | XERS | AFYA |
|---|---|---|
| Price | $6.72 | $15.20 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | $10.00 | ★ $18.10 |
| AVG Volume (30 Days) | ★ 2.8M | 84.6K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 1.53% |
| EPS Growth | N/A | ★ 25.39 |
| EPS | N/A | ★ 1.50 |
| Revenue | $266,137,000.00 | ★ $681,742,784.00 |
| Revenue This Year | $43.89 | $14.70 |
| Revenue Next Year | $20.40 | $8.36 |
| P/E Ratio | ★ N/A | $10.12 |
| Revenue Growth | ★ 42.05 | 14.07 |
| 52 Week Low | $3.14 | $13.47 |
| 52 Week High | $10.08 | $19.90 |
| Indicator | XERS | AFYA |
|---|---|---|
| Relative Strength Index (RSI) | 34.93 | 60.69 |
| Support Level | $6.47 | $14.76 |
| Resistance Level | $7.24 | $15.21 |
| Average True Range (ATR) | 0.29 | 0.34 |
| MACD | -0.02 | 0.08 |
| Stochastic Oscillator | 24.81 | 79.37 |
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.